Pharmaceutical development phases : a duration analysis / Rosa M. Abrantes-Metz, Christopher P. Adams, Albert Metz.
Electronic resources
Record details
- Physical Description: 29 pages : digital, PDF file
- Publisher: Washington, DC : Bureau of Economics, Federal Trade Commission, [2004]
Content descriptions
- General Note:
- "October 2004."GPO Cataloging Record Distribution Program (CRDP).Title from title screen (viewed on June 17, 2008).
- System Details Note:
- Mode of access: Internet from the FTC web site. Address as of 6/17/08: http://www.ftc.gov/be/workpapers/wp274.pdf; current access available via PURL.
Search for related items by subject
- Subject:
- Drug development > United States.
Pharmaceutical industry > United States > Quality control.
Additional Physical Form Titles
| Available in another form: | Pharmaceutical development phases |
Search for related items by series
Accessibility Features
| LDR | 01908cam a2200397Ki 4500 | ||
|---|---|---|---|
| 001 | 12888002 | ||
| 003 | CARDINAL | ||
| 005 | 20080617153021.0 | ||
| 006 | m d f | ||
| 007 | cr c|||||||||| | ||
| 008 | 080617s2004 dcu o f000 0 eng d | ||
| 035 | . | ‡a(OCoLC)232156634 | |
| 040 | . | ‡aGPO ‡beng ‡erda ‡cGPO ‡dMvI | |
| 074 | . | ‡a0535-A-10 (online) | |
| 086 | 0 | . | ‡aFT 1.37/2:274 |
| 100 | 1 | . | ‡aAbrantes-Metz, Rosa M. |
| 245 | 1 | 0. | ‡aPharmaceutical development phases : ‡ba duration analysis / ‡cRosa M. Abrantes-Metz, Christopher P. Adams, Albert Metz. |
| 264 | 1. | ‡aWashington, DC : ‡bBureau of Economics, Federal Trade Commission, ‡c[2004] | |
| 300 | . | ‡a29 pages : ‡bdigital, PDF file | |
| 336 | . | ‡atext ‡btxt ‡2rdacontent | |
| 337 | . | ‡acomputer ‡bc ‡2rdamedia | |
| 338 | . | ‡aonline resource ‡bcr ‡2rdacarrier | |
| 490 | 1 | . | ‡aWorking paper ; ‡vno. 274 |
| 500 | . | ‡a"October 2004." | |
| 500 | . | ‡aGPO Cataloging Record Distribution Program (CRDP). | |
| 500 | . | ‡aTitle from title screen (viewed on June 17, 2008). | |
| 538 | . | ‡aMode of access: Internet from the FTC web site. Address as of 6/17/08: http://www.ftc.gov/be/workpapers/wp274.pdf; current access available via PURL. | |
| 650 | 0. | ‡aDrug development ‡zUnited States. | |
| 650 | 0. | ‡aPharmaceutical industry ‡zUnited States ‡xQuality control. | |
| 700 | 1 | . | ‡aAdams, Christopher P. |
| 700 | 1 | . | ‡aMetz, Albert. |
| 710 | 1 | . | ‡aUnited States. ‡bFederal Trade Commission. ‡bBureau of Economics. ‡0(CARDINAL)140293 |
| 776 | 0 | . | ‡aAbrantes-Metz, Rosa M. ‡tPharmaceutical development phases ‡h29 p. ‡w(OCoLC)56911577 |
| 830 | 0. | ‡aWorking paper (United States. Federal Trade Commission. Bureau of Economics) ; ‡vno. 274. ‡0(CARDINAL)333749 | |
| 856 | 4 | 0. | ‡uhttps://purl.fdlp.gov/GPO/LPS95535 ‡7govdoc ‡yClick for online content. ‡9BHM ‡9BLADEN ‡9BRASWELL ‡9BROWN ‡9BRUNSWICK ‡9BUNCOMBE ‡9BURKE ‡9CALDWELL ‡9CARTERET ‡9CASWELL ‡9CLEVELAND ‡9DAVIE ‡9DUPLIN ‡9FARMVILLE ‡9FORSYTH ‡9FRANKLIN ‡9GRANVILLE ‡9HARNETT ‡9HAYWOOD ‡9HENDERSON ‡9IREDELL ‡9JOHNSTON ‡9LEE ‡9MADISON ‡9MAUNEY ‡9NANTAHALA ‡9NORTHWESTERN ‡9ONSLOW ‡9PERRY ‡9PERSON ‡9POLK ‡9ROBESON ‡9ROCKINGHAM ‡9RUTHERFORD ‡9SAMPSON ‡9SANDHILL ‡9SCOTLAND ‡9STANLY ‡9TRV ‡9WARREN ‡9YANCEY ‡9DEQ_ELC ‡9GHL ‡9GOV_MANSION ‡9HIGH_POINT ‡9NC_ARCHIVES ‡9NC_ART ‡9NC_DOL ‡9NC_DOT ‡9NC_LEG ‡9NC_NATSCI ‡9NC_SHS ‡9CAMDEN ‡9CURRITUCK ‡9DARE ‡9JACKSON ‡9PASQUOTANK |
| 901 | . | ‡a12888002 ‡bgovdoc-script 551d4ae3ca67abb0508bb4ec4a94c4ee27e5d268 56f02804d8d2c388b10e18cb4710490bb175359a ‡c12888002 ‡tbiblio ‡selectronic | |
